| Nov 21 |
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
|
| Nov 21 |
Analysts supportive of Kura/Kirin deal despite major selloff (update)
|
| Nov 21 |
Kura Oncology: A Contender In The Field Of Precision Medicine
|
| Nov 21 |
Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
|
| Nov 21 |
Kura Oncology partners Kyowa Kirin to advance AML treatment
|
| Nov 20 |
Kura stock slides 17% on Kyowa Kirin deal for ziftomenib
|
| Nov 20 |
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
|
| Nov 9 |
Kura Oncology, Inc. (KURA) Q3 2024 Earnings Call Transcript
|
| Nov 8 |
Kura Oncology Inc (KURA) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising Expenses
|
| Nov 7 |
Kura Oncology: Q3 Earnings Snapshot
|
